Decades of Malaria Treatment in Senegal Leave Zero Room for Sensitive Parasites
Genetics

Decades of Malaria Treatment in Senegal Leave Zero Room for Sensitive Parasites

A genomic and laboratory analysis of over 2,000 infections reveals how drug pressure shaped resistant strains while exposing crucial fitness trade-offs.

By Elizabeth Taylor
Published:
Email this Article
Decades of Malaria Treatment in Senegal Leave Zero Room for Sensitive Parasites
Photo by E. Diop on Unsplash

A sweeping genetic analysis of more than two thousand malaria infections collected across Senegal between 2006 and 2022 has revealed how decades of antimalarial treatments have reshaped the parasite population. Researchers tracked 2,805 monogenomic malaria infections, meaning infections driven by a single genetic strain, and found that fully drug-sensitive parasites have become virtually extinct in the region, accounting for less than one percent of all cases.

Tracking Two Decades of Parasite Evolution

The study, published in PLOS Pathogens, provides a detailed look at how Plasmodium falciparum, the parasite responsible for the deadliest form of malaria, adapts to public health interventions. Senegal has rolled out successive treatment and prevention policies over the last twenty years, including sulfadoxine-pyrimethamine combined with amodiaquine for seasonal chemoprevention in children, and artemisinin-based combination therapies as frontline treatments. These drug programs have exerted immense evolutionary pressure on the local parasite population.

To understand the functional consequences of these genetic shifts, the research team successfully adapted 33 clinical parasite isolates to laboratory culture. These isolates represented 26 distinct combined resistance haplotypes, which together accounted for nearly 64 percent of all infections in the genomic dataset. By measuring drug susceptibility and running pairwise competitive growth assays, the authors could connect specific genetic combinations directly to how well the parasites survived drug exposure and competed against one another.

Fig 2: Temporal dynamics of Pfcrt and Pfmdr1 haplotype frequencies across six sites in Senegal, 2006-2022. Analysis included WGS data from 2,160 monogenomic infections with complete genotype calls at the relevant Pfcrt and Pfmdr1 positions. The WT Pfcrt haplotype CVMNK AQNIR (gray/black) was the most common Pfcrt haplotype throughout the study period, whereas CVIET SENTI (red/maroon) was the predominant mutant Pfcrt haplotype. The frequencies of Pfmdr1 NYD and NFD haplotypes appeared relatively stable over time, with overall mean frequencies of 0.47 versus 0.44, respectively. Haplotype frequencies are provided in S5 Table.
Temporal dynamics of Pfcrt and Pfmdr1 haplotype frequencies across six sites in Senegal, 2006-2022. Analysis included WGS data from 2,160 monogenomic infections with complete genotype calls at the relevant Pfcrt and Pfmdr1 positions. The WT Pfcrt haplotype CVMNK AQNIR (gray/black) was the most common Pfcrt haplotype throughout the study period, whereas CVIET SENTI (red/maroon) was the predominant mutant Pfcrt haplotype. The frequencies of Pfmdr1 NYD and NFD haplotypes appeared relatively stable over time, with overall mean frequencies of 0.47 versus 0.44, respectively. Haplotype frequencies are provided in S5 Table. Credit: Katelyn Vendrely Brenneman et al. / PLOS Pathogens

Mutations That Drive Drug Resistance and Fitness Costs

The laboratory tests confirmed that mutations in the Pfcrt gene, traditionally linked to chloroquine resistance, also reduce susceptibility to monodesthyl-amodiaquine, the active breakdown product of amodiaquine. Specifically, parasites carrying the Pfcrt CVIET genetic background combined with additional mutations known as N326S or I356T showed significantly higher half-maximal effective concentration values, indicating reduced drug susceptibility. The Pfdhfr triple mutant haplotype drove high levels of resistance to pyrimethamine, while Pfdhps A437G mutations increased resistance to sulfadoxine.

However, carrying these resistance mutations comes with a biological price. Competitive fitness modeling using a Bradley-Terry statistical approach revealed that the chloroquine-resistance-associated Pfcrt CVIET background imposes a severe growth cost on the parasite in the absence of drugs. Interestingly, this fitness penalty was partially offset when the parasites also carried the Y184F mutation in the Pfmdr1 gene, helping explain how certain resistant strains manage to persist in the population even when drug pressure fluctuates.

Fig 4: Combined Pfdhfr-Pfdhps frequencies in Thiès and Kédougou. WGS data were obtained from monogenomic infections collected from patients in Thiès and Kédougou between 2019 and 2022. The analysis included infections with complete, unambiguous genotype calls at the relevant Pfdhfr and Pfdhps positions (A) In Thiès, the most prevalent combined haplotype was Pfdhfr IRN + Pfdhps IAAKAA. (B) In Kédougou, Pfdhfr IRN + Pfdhps ISGKAA was the most frequently observed haplotype. Haplotype frequencies are provided in S9 Table.
Combined Pfdhfr-Pfdhps frequencies in Thiès and Kédougou. WGS data were obtained from monogenomic infections collected from patients in Thiès and Kédougou between 2019 and 2022. The analysis included infections with complete, unambiguous genotype calls at the relevant Pfdhfr and Pfdhps positions (A) In Thiès, the most prevalent combined haplotype was Pfdhfr IRN + Pfdhps IAAKAA. (B) In Kédougou, Pfdhfr IRN + Pfdhps ISGKAA was the most frequently observed haplotype. Haplotype frequencies are provided in S9 Table. Credit: Katelyn Vendrely Brenneman et al. / PLOS Pathogens

Geographic Differences and Future Prevention Strategies

The genomic data also highlighted geographic divergence within Senegal. While triple mutants in Pfdhfr became nearly fixed nationwide by 2018, mutations in the Pfdhps gene varied between sites. In Thiès, a low-transmission region where seasonal chemoprevention is not used, one specific haplotype predominated, whereas a different haplotype dominated in Kédougou, a high-transmission area receiving multiple monthly rounds of preventive treatment.

Crucially, the study found limited evidence in Senegal for the high-level artemisinin resistance markers or severe antifolate resistance mutations that have emerged in parts of East Africa and Southeast Asia. The authors note that while high frequencies of moderate resistance markers do not automatically render preventive treatments useless, continuous monitoring is vital. Combining genomic surveillance with laboratory phenotyping ensures public health officials can spot dangerous genetic combinations before they compromise malaria control efforts.

The research was published in PLOS Pathogens on November 19, 2026.

Fact Checked

This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.

Last reviewed on .

Article history

  • Latest version

Reference(s)

  1. Brenneman, Katelyn Vendrely., et al. “Genotype-phenotype investigation of evolving mutations associated with antimalarial resistance among Senegalese Plasmodium falciparum malaria parasites.” PLOS Pathogens, vol. 22, no. 11, November 19, 2026, pp. e1014822 Public Library of Science (PLoS), doi: 10.1371/journal.ppat.1014822. <https://doi.org/10.1371/journal.ppat.1014822>.

Cite this page:

Taylor, Elizabeth. “Decades of Malaria Treatment in Senegal Leave Zero Room for Sensitive Parasites.” BioScience. BioScience ISSN 2521-5760, 20 November 2026. <https://www.bioscience.com.pk/en/subject/genetics/genotype-phenotype-investigation-of-evolving-mutations-associated-with-antimalarial-resistance-among-senegalese-plasmodium-falciparum-malaria-parasites>. Taylor, E. (2026, November 20). “Decades of Malaria Treatment in Senegal Leave Zero Room for Sensitive Parasites.” BioScience. ISSN 2521-5760. Retrieved November 20, 2026 from https://www.bioscience.com.pk/en/subject/genetics/genotype-phenotype-investigation-of-evolving-mutations-associated-with-antimalarial-resistance-among-senegalese-plasmodium-falciparum-malaria-parasites Taylor, Elizabeth. “Decades of Malaria Treatment in Senegal Leave Zero Room for Sensitive Parasites.” BioScience. ISSN 2521-5760. https://www.bioscience.com.pk/en/subject/genetics/genotype-phenotype-investigation-of-evolving-mutations-associated-with-antimalarial-resistance-among-senegalese-plasmodium-falciparum-malaria-parasites (accessed November 20, 2026).
End of the article